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Abstract-The circular dichroism (CD) spectra of five myeloma and six hybridoma proteins specific for 
phosphocholine were measured in the 250-310-nm range. The effect on the CD spectra of adding 
phosphocholine was also examined. The five myeloma proteins all had distinctive native spectra and, 
except for M603 and W3207, unique changes occurred on ligand binding. The hybridomas were chosen 
as pairs from each of the three known families of phosphocholine-specific immunoglobulins. Those from 
the T15 or M603 families resembled the appropriate prototype. However, the proteins from the Ml67 
family were all distinctively different in their CD properties. In particular, the hybridoma protein 1016G6 
showed large CD changes on hapten binding and values for the association constant for phosphocholine 
of 1.1 x 10s M-’ and of 5.8 x lo2 M-’ for acetylcholine were obtained by CD spectrophotometric 
titration. The CD properties of the proteins are interpreted in the light of the sequence data so far 
available, including the possible role of the D-segment. 
INTRODUCTION 
The processes by which the repertoire of antibody 
variable regions is generated are now known in 
outline (Tonegawa, 1983). However variation in se- 
quence may not automatically mean variation in 
function, i.e. specificity for antigen (Cohn et al., 1980; 
Kabat, 1981, 1982) and more detailed knowledge of 
the relationship of sequence to specificity is required. 
In particular, the role of the D-segment is not entirely 
clear. This gene segment and its junctions with the 
Vn- and Jr.,-segments form the third 
complementarity-determining region of the heavy 
chain (CDR3). The possibility exists that it may be a 
structural element rather than being directly involved 
in antigen binding (Potter, 1983). 
Extensive sequence data [collected in Kabat et al. 
(1983)] and the X-ray crystallographic analysis of 
M603 Fab (Padlan et al., 1976) make ;he 
phosphocholine-specific immunoglobulins very suit- 
able for studies of structure and function. The orig- 
inal group of mouse myeloma proteins were assigned 
on the basis of their hapten-binding properties to 
three families, typified by T15, M603 and Ml67 
respectively (Leon and Young, 1971). Subsequently, 
various hybridoma proteins specific for phos- 
phocholine were assigned to the same families on the 
basis of idiotypic analyses (Claflin et al., 1981). 
hapten profiles (Andres et al., 1981) and protein 
sequence analyses (Gearhart et al., 1981). The 
hapten-binding studies indicated that the proteins of 
the T15 family are relatively constant in their func- 
tional properties, as are those of the M603 family 
except for some variation in binding of an antigen 
from Proteus morganii. In contrast the proteins of the 
M 167 family are quite diverse in their hapten-binding 
specificities. It may be possible to correlate the vari- 
ations seen in the properties of proteins of the Ml67 
family with differences in their amino-acid sequences, 
Circular dichroism (CD) can provide additional 
information on both structural and functional as- 
pects of antibodies. Earlier work on the 
phosphocholine-binding myeloma proteins (Morris 
et al., 1974) showed that the Fv regions contribute 
strongly to the near-u.v. CD. Spectra in this region, 
250-310 nm, arise chiefly from tyrosine and tryp- 
tophan chromophores. The structural differences 
among the three prototypic myeloma proteins gave 
rise to considerably different CD spectra in this 
region. In addition, functional differences were evi- 
dent since addition of the hapten phosphocholine 
caused different changes in the spectra of the three 
proteins. In this paper, we report further CD studies 
of phosphocholine-specific myeloma and hybridoma 
proteins, particularly the unique hybridoma protein, 
101.6G6. This protein, though assigned to the M 167 
family (Claflin et al., 1981; Andres et al., 1981) has 
an H-chain derived from the I/II member (Clarke et 
al., 1982) of the set of four T15 genes (Crews et al., 
1981), while the other proteins are all derived from 
the V1 gene. It also has a different D-segment (Clarke 
et al., 1983). 
MATERIALS AND METHODS 
Ascites fluids containing the MS1 1, M603 and T1.5 
proteins were given by Dr M. Potter, W3207 ascites 
fluid was given by Dr L. Hood and J558 ascites fluid 
by Dr B. Clevinger. The tumor lines MOPC 167 and 
MOPC 104E were propagated in this laboratory. The 
phosphochohne-specific proteins were purified using 
the affinity medium of Chesebro and Metzger (1972) 
or a medium prepared by reacting p-aminophenyl- 
phosphocholine with an N-hydroxysuccinimide- 
activated agarose gel [Affi-Gel 10 (Bio-Rad Labora- 
tories Ltd, Mississauga, Ontario)]. Neither the ascites 
fluids nor the purified proteins were reduced, and the 
predominant ohgomeric form was the dimer in all 
cases. M104E and 5558 were purified on the dextran 
affinity medium of Hiramoto et al. (1972). M3 15 was 
purified from ascites fluid (Litton Bionetics Inc.) with 
a &-dinitrophenyl-lysine Affi-Gel IO column. The 
hybridoma proteins have been previously described 
(Claflin et al., 198 1). 
CD spectra were recorded on a Cary 61 instru- 
ment. The data are presented as mean residue molar 
ellipticities, [Q],,,, assuming a mean residue wt of 
110. Protein concentrations were estimated using 
the extinction coefficient, A :x”R m’ = 1.35, except for 
Ml04E where 1.60 (Leon ef ul., 1970) was used. The 
samples were in 0.15 M NaCI. 0.01 A4 phosphate 
buffer. pH 7.3, except where noted. 
RESULTS 
Phosphocholine -spec$c myeloma proteins 
In Fig. 1, the CD spectra of M511 and W3207 in 
the aromatic region are compared to the spectra of 
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Fig. 1. CD spectra in the aromatic region of mouse my- 
eloma proteins, all in the dimeric IgA form: T15 (-), 
W3207 (--). M603 (G-), M511 (,...) and Ml67 (---). 
M603. T15 and M167. the prototypes for the three 
phosphocholine families. The spectra were recorded 
with non-reduced samples, predominantly in the 
dimeric IgA form, unlike those reported previously 
for M603. T15 and Ml67 (Morris cf ul., 1974). In 
the far-u.v. region, the M511 and W3207 proteins 
both had [O],,, values at 217 nm of 
- 6700 degrees cm’jdmole, greater than those of the 
other proteins which were between -4100 and 
- 5600 degrees cm’:dmole (Morris et al.. 1974). It is 
apparent that M511 resembles M 167 in its CD spec- 
trum, as might be anticipated from its idiotypy and 
overall sequence homology. W3207, though a mem- 
ber of the M603 family, has a CD spectrum more like 
that of Tl5. Clearly even the limited sequence 
differences within a family affect the structures of 
these proteins as reflected in the CD properties of 
their aromatic residues. 
Addition of the ligand phosphocholine in site- 
saturating amounts caused changes in the CD spectra 
that were distinct for nearly all the proteins (Fig. 2). 
The exception is the W32077M603 pair. which both 
showed similar positive shifts in ellipticity. The 
hapten profiles of M603 and W3207 are also similar. 
though their reactivities towards the P. /nol;gu~zij 
antigen are a little different (Andres et d.. 1981). In 
the case of M511, the spectral change produced by 
phosphocholine binding was greater than that of the 
other four proteins. particularly M167. Though re- 
lated in many ways. M 167 and M51 I differ in hapten 
profile (Andres et ul.. 1981) and the association 
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Fig. 2. CD difference spectra of the proteins of Fig. 1. 
calculated as 0 (protein plus phosphocholine) -0 (native 
protein). Tl5 (---), W3207 (--). M603 (-.-). M511 (....) 
and Ml67 (---). The errors are estimated as + I 
degree. cm2:dmole. 
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Fig. 3. CD spectra of dextran-specific myeioma proteins. 
Upper diagram, M104E (-), M104E plus nigerose (---) 
and M315 (....): lower diagram, 5558 (--) and 5558 plus 
nigerose (---). 
constants for phospho~holine of M511 is 10 times 
lower than that of Ml67 (Metzger et uf., 1971). 
effect of &type dtyerences on the CD spectra 
The phosphocholine-specific myeloma proteins 
above are all IgAs, whereas the hybridoma proteins 
specific for the same determinant are often IgMs. To 
allow comparison of the hyb~doma proteins to the 
myeloma proteins, the effect of the class change on 
the CD spectrum was investigated. An almost ideal 
pair of myeloma proteins for this purpose are the 
dextran-specific proteins Ml04E, an IgM (Leon et 
al., 1970): and 3558, an IgA (Lundblad ef af., 1972). 
These two proteins differ only in two residues in their 
Fd regions and have identical L-chains. The sequence 
at residues 96H and 97H, the D-Jw junction, is 
Tyr-Asp in M 104E and Arg-Tyr in 5558 (Shilling et 
al., 1980). The CD spectra of the two proteins (Fig. 
3) are very similar in form, only a minor difference 
near 280 nm being apparent. Hence the class change 
from IgA to IgM has little effect when comparing CD 
spectra of mouse immunoglobulins. 
When the specific hapten, nigerose, was added in 
site-saturating amounts, the CD spectra of M104E 
and 5558 underwent very similar changes (Fig. 3); the 
slight difference around 280nm is within experi- 
mental error. These small changes in the tyrosine 
region occurring with M104E and 5558 on ligand 
binding contrast with the large changes, particularly 
in the tryptophan region, seen with M315 when this 
IgA binds dinitrophenyl haptens (Rockey and Freed, 
1976). The CD spectrum of M315 resembles those 
of Ml04E and 5558 (Fig. 3) possibly due to the 
homology of its RS light chain to the ;1, of M lO4E and 
5558 (Dugan et al., 1973). 
CD spectra of hybridoma proteins 
Two hybridoma proteins from each of the three 
families of phospho~holine-binding proteins were 
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Fig. 4. CD spectra of hybridoma proteins of the T15 family. 
Protein 59.6C5.1 (-), 103.1C9.1 (--) and the myeloma 
protein T15 (...,). 
studied, four of the six being IgMs. It is worth noting 
that relatively little protein, approx. 1 mg, is needed 
to obtain a CD spectrum and to examine the effect 
of one hapten. The spectra are presented in Figs 4-6. 
Correct assignment of all these proteins to their 
respective families on the basis of the shape of their 
CD spectra would not have been possible. Proteins 
59.6C5.1 (an IgG3) and 103.1C9.1 (an IgG2) might 
have been correctly assigned to the T15 family (Fig. 
4) and 100.6622 and 100.6F9.1 to the M603 family 
(Fig. 5), but the two proteins from the Ml67 family, 
101.3C2.2 and 101.6G6 (Fig. 6), show a greater 
resemblance to T 15 and M603 respectively. CD spec- 
tra do not therefore offer an accurate way of classi- 
fying hyb~doma proteins into families. 
Ligand effects on the CD spectra were examined 
for most of the proteins. The 59.6C5.1 protein be- 
haved similarly to T15 and 100.662.2 and 100.6F9.1 
to M603, as expected. The behavior of the M167-type 
proteins was markedly different (Fig. 6). 101.3C2.2 
gave a difference spectrum resembling that of M51 t 
in shape but of only about half the A6 magnitude. 
The 101.6G6 protein gave an extremely large change 
described below. 
Unique properties of the hybridoma protein 101.6C 6 
In its native CD spectrum (Fig. 6) 101.6G6 re- 
308 N. MARTIN YOUNG ct ul. 
-60 
I I I I I 
260 280 300 
WAVELENGTH (nm) 
Fig. 5. CD spectra of hybridoma proteins of the M603 
family. Protein 100.662.2 (,‘..), 100.6F9.1 (--) and M603 
(-). 
sembles M603 more than M167. When phos- 
phochoiine is bound, a very large change occurs in 
the CD spectrum, while binding of acetylcholine 
causes a qualitatively similar change but of only half 
the A@ magnitude. This contrasts with the behavior 
of Tl5 where the two haptens caused very similar 
spectral changes (Morris 0~ u/., 1974). 
In these experiments, phosphocholine was added as 
the calcium salt, and calcium binding can cause 
changes in spectroscopic properties of immuno- 
globulins (Bhattacharjee and Glaudemans, 1983). 
Addition of calcium ion to the native 101.6G6 did not 
affect the CD spectrum and, when phosphocholine 
was added as the sodium salt to 101.6G6 in 20mM 
EDTA or 5 mM CaCL, the difference CD spectra and 
spectrophotometric titration curves (see below) were 
within experimental error. Hence calcium ions are 
not responsible for any part of the spectral differences 
and do not play a role in ligand binding. 
The magnitude of the CD changes allowed the 
association constants for phosphocholine and acetyl- 
choline to be measured by CD spectrophotometric 
titrations. Previous studies (Clarke ct ul., 1983) using 
fluorescence spectroscopy had not given such data, as 
no changes occurred in the fluorescence properties of 
101.6G6 when phosphocholine was bound. This is in 
surprising contrast to the effects seen in the CD. The 
titration data (Fig. 7) were recorded at 290 nm: 
similar results were obtained measuring at 265 nm. 
Scatchard plots of the titration data (Fig. 8) were 
obtained using the equation ric. = nK - rK. where r 
is the number of moles of ligand bound per mole of 
combining site, assuming a mol. wt of 75,000 per site, 
c is the concentration of free ligand and K is the 
association constant. For phosphocholine, K was 
1.1 + 0.1 x 10’ M -’ and for acetylcholine 5.8 x 
10’ M ‘. The ratio of the two K-values lies between 
the ratios for M 167 and T15 (or M603) obtained in 
inhibition experiments (Leon and Young. 1971). 
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Fig. 6. CD spectra of hybridoma proteins of the M511 family. Left panel, protein 101.3C2.2 (--) and 
with phosphocholine added (---); MS1 1 (- ) and with phosphocholine added (--). Right panel, protein 
101.6~6 (---) and with acetylcholine added (---) or phosphocholine added (-p). Each ligand was added 
in saturating amounts. 
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Fig. 7. CD spectrophotometric titrations of 101.6G6 with 
the sodium salt of phosphocholine in: (a) 5 mM CaCl,, 
0.15 M NaCl, 0.02 A4 imidazole buffer, pH 7.2 (a); and (b) 
0.15 M NaCl, 20 mM EDTA, pH 7.2 (0). 
DISCUSSION 
CD differences between related proteins in the 
aromatic region of their spectra can arise in two ways. 
Firstly, there may be some direct sequence differences 
involving tyrosine and tryptophan residues being 
replaced by other residues. Secondly, sequence 
differences of residues nearby tyrosine and tryp- 
tophan residues in the three-dimensional structure of 
the protein may affect their conformation or influence 
their electronic properties. To analyse the latter, 
extensive model building and interpretation of ligand 
binding would be necessary. Studies of this type have 
been undertaken for M315 (Padlan et al., 1977) 5539 
(Feldman et al., 1981), Ml67 (Coutre et al., 1981) and 
M104E (Hovis, 1982). Comparison of the direct 
changes in sequence involving aromatic residues is 
more readily undertaken, but is much less complete. 
Amino-acid sequence data for the five 
phosphocholine-specific myeloma proteins (Kabat et 
al., 1983) and two of the hybridoma proteins (Clarke 
et al., 1983) are summarized in Table 1 for those 
CDRs that show differences involving tyrosine or 
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Fig. 8. Scatchard plot of the data from the CD spec- 
trophotometric titrations of 101.6G6. Phosphocholine ti- 
trations in CaCl, (0) and EDTA (0) from Fig. 7, and an 
acetylcholine titration (a). 
tryptophan residues. M603 is taken as the prototype 
since its structure is being determined by X-ray 
crystallography (Padlan et al., 1976). The aromatic 
sequence differences occur mainly in the CDRl of the 
L-chain and the CDR3 of the H-chain. The role of 
the CDR3 in antibodies has not been absolutely 
established. It has been suggested that it has a 
structural rather than antigen-binding function (Pot- 
ter, 1983). It is probable that the variation in the 
native CD spectra among the proteins arises mainly 
from the differences in their CDR3 sequences. 
The variation in the CD effects upon phos- 
phocholine binding (Fig. 2) shows that the aromatic 
residues in the binding sites are not equivalent in 
properties. Either the tyrosine and tryptophan resi- 
dues common to the five take up different con- 
formations in each case, in either native or ligand- 
bound states or both, or additional aromatic residues 
are affected by binding. The source of such additional 
residues would predominantly be CDR3, which 
would imply that antigen binding affects this region. 
The pair of dextran-specific myeloma proteins 
M104E and 5558 differ also at the D-J, junction, 
with Tyr-Asp in M104E becoming Arg-Tyr in 5558, 
at residues 96 and 97 @chilling et al., 1980). No 
significant differences between the two proteins in the 
effect of binding the hapten nigerose were seen (Fig. 
3) hence these tyrosines are not different in their CD 
properties. A recent model for the M 104E site and its 
Table I. Sequence data for the CDRs that show differences in tyrosine and tryptophan residues 
H-chain CDR3” 
L-chain 
Protein V, D JH (compared to M603) 
M603 N YYGST WYF 
W3207 N YYKYDL WYF Sequence not available 
100.6F9 N YYDGSY WYF h 
Tl5 D YYGSSY WYF 27CL+Y;32F-Y:55E-Y;92H+Y 
Ml67 D ADYGDSYF GYF 27D N + Y; 32 F + Y 
M511 D GDYGSSY WYF 27DN-Y; 32F+ Y 
101.6G6 A NWDG F 27D N + Y; 32 F 4 Yh 
“CDRs I and 2 have no differences in their aromatic residues. 
%equence known only through CDRl (Clarke er al., 1983). 
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binding of nigerose (Hovis, 1982) includes a hydro- 
gen bond from the hydroxyl of Tyr 96H to the 
hapten. Thus differences in the behavior of the two 
proteins might have been anticipated, but are not 
evident in these CD experiments. 
Additional spectra and sequence data on hybrid- 
oma proteins should help with the analysis begun 
above. The findings with the present group showed 
that hybridoma proteins of the T15 and M603 fam- 
ilies are generally consistent in their CD properties 
while the Ml67 family is a rather variable one. This 
confirms the results obtained by ligand profiling 
(Andres et al., 1981). The four members of the Ml67 
family studied here all differed in the shape of their 
native spectra and, more importantly, in the effect of 
hapten binding on their CD. The latter effects ranged 
from a small change in the case of M 167, a larger one 
for 101.3C2.2, a still larger one for M511, which gave 
the greatest change of the group of myeloma pro- 
teins, to the very large change occurring with 
101.6G6. Hence, the variation in the Ml67 family 
seen in the binding of analogs of phosphocholine 
(Andres et al., 1981) is shown by the CD results to 
extend to the details of the interaction of the proto- 
typic hapten, phosphocholine, with the combining 
sites. This family should therefore be particularly 
valuable for correlating the variation of function with 
structure, when the necessary sequence data are 
available and the M 167 structural model (Coutre et 
al., 1981) is refined. 
The hybridoma protein 101.6G6 has been classified 
as a member of the Ml67 family on the basis of 
idiotypy and ligand profile (Andres et al., 1981). 
Sequence work has shown that its L-chain is homol- 
ogous to that of M 167 (Clarke et al., 1983). However, 
its H-chain is derived from the VII member of the 
T15 gene family (Clarke et al., 1982) rather than the 
VZ gene used by the other phosphocholine-binding 
immunoglobulins (Crews et al., 1981). The H-chain 
of M47A is also derived from the VII gene and 
formed phosphocholine-binding immunoglobulins 
when combined in vitro with the 101.6G6 or M511 
L-chains (Pierce et al., 1984). Hence 101.6G6 can be 
considered as the prototype of a fourth family of 
phosphocholine-specific immunoglobulins. 
The magnitude of the CD spectral changes seen 
with 101.6G6 is unusually large for a protein-ligand 
interaction. The different effects of acetylcholine and 
phosphocholine binding to 101.6G6 indicate different 
interactions around the quaternary ammonium moi- 
eties of the two ligands are occurring. This situation 
is analogous to previous results, obtained by res- 
onance Raman spectroscopy, on the variation in 
behavior around the nitro groups of various dinitro- 
phenyl ligands when bound to M3 15 and M460 
(Kumar et al., 1978). That an antibody combining 
site may adopt different conformations around ap- 
parently homologous regions of hapten is in accord 
with current views of the flexible nature of protein 
active sites in general. 
The association constant obtained by CD spec- 
trophotometric titration for 101.6G6 at 1 x 10’ $! ’ 
is slightly below that of M 167. I .2 x 10’ M ’ at 
pH 8.0, but well above that of M511. 1.6 x IO” M ’ 
(Metzger et al., 1971). Hence the apparently large 
conformational change accompanying hapten bind- 
ing does not reduce the effectiveness of 101.6G6 as a 
phosphocholine-binding protein, and evidently im- 
munoglobulins derived from the VII gene can be as 
effective as those from the VI gene. 
Several structural features may contribute to the 
large CD effects seen with 101.6G6. The differences 
between the 101.6G6 and other H-chain CDRs in- 
clude an interesting difference in CDRl In 101.6G6 
the sequence Tyr-Tyr-Met-Ser occurs instead of the 
Phe-Tyr-Met-Glu sequence of the other proteins. 
The latter is characteristic of phosphocholine-binding 
immunoglobulins (Kabat et al., 1976) and includes 
residues that contact the hapten (Padlan et al., 1976). 
The additional tyrosine, a potential CD chromo- 
phore, in the CDR 1 of 10 1.6G6 may be important for 
the protein’s spectroscopic behavior. Secondly, the 
D-seglnent of 101.6G6 is considerably different in 
sequence and creates a much shorter CDR3 than 
those of the other proteins (Clarke er al.. 1983). It 
contains no tyrosine residues and one tryptophan, 
whereas the others have several tyrosines and except 
M167. one tryptophan. Finally, there may be 
differences in the overall association of a VII gene 
H-chain with a VK24 L-chain compared to the 
VZ&VK24 system that necessitate greater site rear- 
rangement upon ligand binding. 
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